<DOC>
	<DOCNO>NCT02277600</DOCNO>
	<brief_summary>This open-label , single sequence , 2-cohort , drug-drug interaction study healthy male female subject . There formal hypothesis , however , expect coadministration BMS-663068 darunavir ( DRV ) /cobicistat ( COBI ) COBI increase systemic exposure BMS-626529 .</brief_summary>
	<brief_title>A Phase 1 Antiretroviral Drug-Drug Interaction Study Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>Healthy male female Nonsmoking subject Ages 18 50 year Inclusive body mass index 18.0 32.0 kg/m2 , inclusive Women childbearing potential Must agree follow instruction method contraception duration study plus 34 day posttreatment completion Any history acute chronic medical surgical illness Personal family history hemophilia A B Other protocol define exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>